课题基金 / 基金详情

Study on the mechanisms in which FDG accumulates in the evaluation of musculoskeletal tumors

Study on the mechanisms in which FDG accumulates in the evaluation of musculoskeletal tumors
FDG积累在肌肉骨骼肿瘤评价中的机制研究
批准号:
12671395
负责人:
WATANABE Hideomi
金额:
$2.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2003

项目摘要

项目成果

WATANABE Hideomi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In the present study, we elucidate the usefulness and the limit of FDG PET in the evaluation of musculoskeletal tumors. We tried other PET tracers, ^<18>F-alpha-methyl tyrosine and ^<11>C-choline for the tumor imaging and demonstrated their superiority to FDG. In schwannoma series only positive venous tumor staining at DSA correlated significantly with the degree of FDG accumulation, suggesting that the SUV for FDG reflects the degree of tumor vascularity in schwannomas. On the other hand, the pooling and cotton-wool staining depicted in DSA was found to be significantly correlated with FDG accumulation of hemangiomas, suggesting that localized blood retention-induced ischemia may accelerate anaerobic glycolysis which leads to high FDG uptake. Hypoxic condition has induced augmentation of AMF/PHI/GPI, which stimulated motile and metastatic capacities, suggesting a correlation of AMF augmentation and hypoxia related glycolysis activation. By the basic research the role of AMF/PHI/GPI and the receptor in the development of lung cancer. The signal transduction system of AMF/PHI/GPI stimulation involved the activation of integrin-beta, KIF3A, and GDI-beta by using adenovirus transfection system. The results obtained from the present investigations provide a new mechanisms involved in the progression of FDG-accumulated musculoskeletal tumors.
期刊论文(32)
专著(0)
科研奖励(0)
会议论文
Hatayama K, et al.: "Evaluation of humang : oma by PET : A role in multi-modality approach."J.Comput.Assoc.Tomograph. 27. 70-77 (2003)
Hatayama K 等人:“通过 PET 评估人类肿瘤:在多模态方法中的作用。”J.Comput.Assoc.Tomograph。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Torimura T, et al.: "Autocrine motility factor enhances hepatoma cell invasion across the basement membrane through activation of integrin"Hepatology. 34. 62-71 (2001)
Torimura T 等人:“自分泌运动因子通过整合素的激活增强肝癌细胞跨基底膜的侵袭”肝病学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Adel Refaat Ahmed, et al.: "Schwannoma of the extremities : the role of PET in preoperative planning"Eur. J. Nucl. Med.. 28. 1541-1551 (2001)
Adel Refaat Ahmed 等人:“四肢神经鞘瘤:PET 在术前计划中的作用”Eur。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hideomi Watanabe, et al.: "PET imaging of musculoskeletal tumors with fluorine-18 alpha-methyltyrosine : Comparison with fluorine-18 fluorodeoxyglucose PET."Eur.J.Nucl.Med.. 27. 1509-1517 (2000)
Hideomi Watanabe 等人:“用氟 18 α-甲基酪氨酸对肌肉骨骼肿瘤进行 PET 成像:与氟 18 氟脱氧葡萄糖 PET 的比较。”Eur.J.Nucl.Med.. 27. 1509-1517 (2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
32
    The role of motile activity of mesenchymao stem cells in regeneration of musculoskeletal organs
    • 批准号:
      16591472
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.37万
    • 财政年份:
      2004
    • 负责人:
      WATANABE Hideomi
    • 依托单位:
    Apoptosis activated in fibrosarcoma growth
    • 批准号:
      09671471
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.98万
    • 财政年份:
      1997
    • 负责人:
      WATANABE Hideomi
    • 依托单位:
    Role of autocrine motility factor in fibrosarcoma
    • 批准号:
      05671198
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.34万
    • 财政年份:
      1993
    • 负责人:
      WATANABE Hideomi
    • 依托单位:
    国内基金
    海外基金
    间位芳纶(PMIA)短切纤维-涤纶(PET)浆粕复合纸的制备设备研发
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      许红伍
    • 依托单位:
    基于18F-FAPI-04 PET/CT与增强CT的Suidan评分在卵巢癌减瘤术前评估中的价值比较研究
    • 批准号:
      2026JJ81876
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      戴嘉舜
    • 依托单位:
    基于高灵敏度PET/CT的碳离子放疗剂量验证与疗效预测研究
    PET分子影像评估肾癌碳酸酐酶9表达异质性及其对靶免联合治疗响应的预测作用与机制研究
    • 批准号:
      JCZRLH202600197
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位: